LIFECORE BIOMEDICAL, INC. Other Current Liabilities
LIFECORE BIOMEDICAL, INC. (LFCR) had Other Current Liabilities of $1.25 million as of 2019-11-24, per its 10-Q filed 2020-01-02.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:OtherLiabilitiesCurrent · last filed 2020-01-02
- 2019-11-24: Other Liabilities, Current $1.25M.
- 2019-08-25: Other Liabilities, Current $1.90M.
- 2019-05-26: Other Liabilities, Current $1.74M.
- 2019-02-24: Other Liabilities, Current $1.98M.
| Period end | Other Liabilities, Current |
|---|---|
| 2019-11-24 | $1.25M 10-Q · filed 2020-01-02 |
| 2019-08-25 | $1.90M 10-Q · filed 2019-10-03 |
| 2019-05-26 | $1.74M 10-Q · filed 2020-01-02 |
| 2019-02-24 | $1.98M 10-Q · filed 2019-04-04 |
| 2018-11-25 | $4.77M 10-Q · filed 2019-01-07 |
| 2018-08-26 | $5.56M 10-Q · filed 2018-10-05 |
| 2018-05-27 | $5.28M 10-K · filed 2019-08-01 |
| 2018-02-25 | $6.42M 10-Q · filed 2018-04-05 |
| 2017-11-26 | $6.86M 10-Q · filed 2018-01-05 |
| 2017-08-27 | $7.54M 10-Q · filed 2017-09-28 |
| 2017-05-28 | $8.39M 10-K · filed 2018-08-09 |
| 2017-02-26 | $2.03M 10-Q · filed 2017-04-07 |
| 2016-11-27 | $1.98M 10-Q · filed 2017-01-05 |
| 2016-08-28 | $1.99M 10-Q · filed 2016-09-29 |
| 2016-05-29 | $1.74M 10-K/A · filed 2018-03-15 |
| 2016-02-28 | $1.73M 10-Q · filed 2016-03-30 |
| 2015-11-29 | $1.67M 10-Q · filed 2016-01-07 |
| 2015-08-30 | $1.53M 10-Q · filed 2015-10-01 |
| 2015-05-31 | $1.69M 10-K · filed 2016-08-01 |
| 2015-03-01 | $1.69M 10-Q · filed 2015-04-02 |
| 2014-11-30 | $1.65M 10-Q · filed 2015-01-09 |
| 2014-05-25 | $2.02M 10-Q · filed 2015-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |